NextCure, Inc. Net Income Loss

• NextCure, Inc. showed a decrease of -0.3% in Net Income Loss from 2024 to 2025.
• This data is from NextCure, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), NextCure, Inc.'s Net Income Loss has declined by 144.9%.
• Historical annual values: Fiscal year 2025: -$55.84 million | Fiscal year 2024: -$55.65 million | Fiscal year 2023: -$62.72 million | Fiscal year 2022: -$74.73 million | Fiscal year 2021: -$69.39 million | Fiscal year 2020: -$36.60 million | Fiscal year 2019: -$33.74 million | Fiscal year 2018: -$22.80 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026